Cybin (OTCMKTS:CLXPF) Stock Price Up 2.7% – Here’s Why

Shares of Cybin Inc. (OTCMKTS:CLXPFGet Free Report) were up 2.7% during trading on Thursday . The company traded as high as $7.46 and last traded at $7.34. Approximately 222,880 shares changed hands during trading, a decline of 60% from the average daily volume of 551,962 shares. The stock had previously closed at $7.15.

Cybin Trading Up 3.7 %

The stock has a market cap of $1.12 billion and a price-to-earnings ratio of -31.54. The firm’s 50-day moving average is $9.03 and its two-hundred day moving average is $8.47.

Cybin Company Profile

(Get Free Report)

Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.

Further Reading

Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.